ATM, R., D, I., CG, B., R, C., ML, N., F, A., . . . N, L. (2026). Correction to: Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis. American journal of clinical dermatology, 27(4), 855. https://doi.org/10.1007/s40257-026-01025-2
Chicago Style (17th ed.) CitationATM, Rønnstad, et al. "Correction to: Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis." American Journal of Clinical Dermatology 27, no. 4 (2026): 855. https://doi.org/10.1007/s40257-026-01025-2.
MLA (9th ed.) CitationATM, Rønnstad, et al. "Correction to: Real-World Evidence of Effectiveness and Safety of Abrocitinib, Baricitinib and Upadacitinib in Atopic Dermatitis: A Systematic Review and Meta-Analysis." American Journal of Clinical Dermatology, vol. 27, no. 4, 2026, p. 855, https://doi.org/10.1007/s40257-026-01025-2.